債券: TEVA/N
以下はTEVA PHARMACEUTICAL INDUSTRIESの社債のリストです。市場のボラティリティが高まった時に社債の安定感は増す、という理由で選ばれることが多いものです。価格や利回りなどの統計データを研究して、信頼の置ける投資先を見つけましょう。
シンボル | 最終利回り % | 価格 % | クーポン % | 満期日 | 発行残高 | 額面金額 | 最低額面 | 発行体 |
|---|---|---|---|---|---|---|---|---|
| TTEVA4608603Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028 | 7.00% | 99.25% | 6.75% | 2028-03-01 | 255 K USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5034099Teva Pharmaceutical Finance Netherlands III BV 7.125% 31-JAN-2025 | 6.97% | 100.15% | 7.13% | 2025-01-31 | 425.259 M USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTFACTEVA P.FI.NL III 16/46 | 6.06% | 74.12% | 4.10% | 2046-10-01 | 2 B USD | 1,000.00 USD | 2,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| UUS88163VAD1TEVA PHARM.FIN. 2036 | 5.84% | 102.62% | 6.15% | 2036-02-01 | 789.428 M USD | 1,000.00 USD | 2,000.00 USD | Teva Pharmaceutical Finance Co. LLC |
| TTEVA4914602Teva Pharmaceutical Finance Netherlands III BV 7.125% 31-JAN-2025 | 5.84% | 101.25% | 7.13% | 2025-01-31 | 1.255 M USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| XXS219821395TEVA PHARM FINANCE NL II 6% GTD SNR NTS 31/01/2025 EUR100000 | 5.71% | 100.29% | 6.00% | 2025-01-31 | 410.607 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| TTEVA5549924Teva Pharmaceutical Finance Netherlands III BV 8.125% 15-SEP-2031 | 5.59% | 114.76% | 8.13% | 2031-09-15 | 500 M USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| UUS88167AAP6TEVA P.F.III 21/27 | 5.51% | 98.16% | 4.75% | 2027-05-09 | 1 B USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5549923Teva Pharmaceutical Finance Netherlands III BV 7.875% 15-SEP-2029 | 5.45% | 110.63% | 7.88% | 2029-09-15 | 600 M USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| UUS88167AAQ4TEVA P.F.III 21/29 | 5.41% | 98.84% | 5.13% | 2029-05-09 | 1 B USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTFABTEVA P.FI.NL III 16/26 | 5.35% | 95.80% | 3.15% | 2026-10-01 | 3.378 B USD | 1,000.00 USD | 2,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA4608604Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028 | 5.34% | 104.41% | 6.75% | 2028-03-01 | 1.25 B USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| XXS259280419TEV.P.F.N.II 23/31 | 4.78% | 118.48% | 7.88% | 2031-09-15 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS259280443TEV.P.F.N.II 23/29 | 4.61% | 112.34% | 7.38% | 2029-09-15 | 800 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS181372460TEVA PH.F.NL.II 18/25 | 4.50% | 100.00% | 4.50% | 2025-03-01 | 494.346 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS240660717TEV.P.F.N.II 21/30 | 4.40% | 99.87% | 4.38% | 2030-05-09 | 1.5 B EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS143974936TEVA PH.F.NL.II 16/28 | 4.08% | 90.82% | 1.63% | 2028-10-15 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS121104407TEVA PH.F.NL.II 15/27 | 4.06% | 94.80% | 1.88% | 2027-03-31 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS240660709TEV.P.F.N.II 21/27 | 4.00% | 99.37% | 3.75% | 2027-05-09 | 1.1 B EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| TTEVA.GJTeva Pharmaceutical Finance Co. LLC 0.25% 01-FEB-2026 | 2.52% | 97.00% | 0.25% | 2026-02-01 | 22.88 M USD | 1,000.00 USD | 1,000.00 USD | Teva Pharmaceutical Finance Co. LLC |
| CCH33382750TEVA PH.FI.NL IV 16-25 | 2.34% | 98.68% | 1.00% | 2025-07-28 | 350 M CHF | 5,000.00 CHF | 5,000.00 CHF | Teva Pharmaceutical Finance Netherlands II BV |
| TT7AATEVA PH.F.NL.II 16/24 | 1.25% | 99.88% | 1.13% | 2024-10-15 | 626.919 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| TTEVA3666246IVAX LLC 1.875% 15-DEC-2024 | — | — | 1.88% | 2024-12-15 | 333 M USD | 1,000.00 USD | 1,000.00 USD | IVAX LLC |